Drug – bio-affecting and body treating compositions – Radionuclide or intended radionuclide containing; adjuvant...
Patent
1988-08-05
1989-09-26
Maples, John S.
Drug, bio-affecting and body treating compositions
Radionuclide or intended radionuclide containing; adjuvant...
540577, A61K 4902, C07D48704
Patent
active
048698954
ABSTRACT:
A compound of the formula: ##STR1## wherein T is tritium; is described as well as intermediates for its preparation. The compound of formula I is useful in vivo for detecting the presence of benzodiazepine receptor occupiers in a warmblooded animal.
REFERENCES:
patent: 4239744 (1980-12-01), Paul et al.
patent: 4280993 (1981-07-01), Braestrup et al.
patent: 4436662 (1984-03-01), Fryer et al.
Abstracts, Society for Neuroscience, vol. 10, Oct. 10-15, 1984.
Eu. Journal of Pharmacology, 113 (Jul. 11, 1985) 147-148.
Proc. Nat. Acad. Sci. (USA) 77, pp. 1666-1670 (1980).
Berry Clark W.
Burger Walter
Liebman Arnold A.
Boxer Matthew
Hoffmann-La Roche Inc.
Leon Bernard S.
Maples John S.
Saxe Jon S.
LandOfFree
Radiolabeled benzazepine does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Radiolabeled benzazepine, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Radiolabeled benzazepine will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-186406